학술논문
Efficacy, safety, and tolerability of RBP-7000 once-monthly risperidone for the treatment of acute schizophrenia: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study
Document Type
Article
Author
Source
In: Journal of Clinical Psychopharmacology . (Journal of Clinical Psychopharmacology, 1 April 2016, 36(2):130-140)
Subject
Language
English
ISSN
1533712X
02710749
02710749